Conventional Versus Convenience: Clinician Collected or At-Home Collected Testing for Sexually Transmitted Infections

Sexually transmitted infections (STIs) have been spiking in recent years. [1]

To help slow the spread of STIs, it’s important to test early in the instance of a possible exposure, even before the appearance of any signs and symptoms. Early and accurate testing can also help reduce the risks of causing complications for the patient.

As with most public health strategies, there isn’t just one answer as to how STI testing should be implemented. For example, at-home sample collection can increase accessibility to testing, while healthcare provider (HCP) sample collection can ensure consistency.

Read our latest white paper to learn more about both conventional and convenient approaches in STI testing.

First name

Last name

Company / institution

Country / region

Zip / postal code

City

Phone number (optional)

Job role (optional)

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information about events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

Phone

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com

I acknowledge Thermo Fisher Scientific (including its affiliates) willl process my Personal Information according to its Privacy Policy, which includes information about my rights.

Reference:

1. Centers for Disease Control and Prevention. “Sexually Transmitted Infections Prevalence, Incidence, and Cost Estimates in the United States.” Centers for Disease Control and Prevention, 25 Jan. 2021, www.cdc.gov/std/statistics/prevalence-2020-at-a-glance.htm.